These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3890150)

  • 1. Characterization of immunoregulatory cytokines produced by epidermal cells.
    Luger TA; Köck A; Danner M
    Scand J Immunol; 1985 May; 21(5):455-62. PubMed ID: 3890150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic separation of distinct epidermal cell-derived cytokines.
    Köck A; Luger TA
    J Chromatogr; 1985 Jun; 326():129-36. PubMed ID: 3897254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal cells synthesize a cytokine with interleukin 3-like properties.
    Luger TA; Wirth U; Köck A
    J Immunol; 1985 Feb; 134(2):915-9. PubMed ID: 3917479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human keratinocytes and epidermoid carcinoma cell lines produce a cytokine with interleukin 3-like activity.
    Danner M; Luger TA
    J Invest Dermatol; 1987 Apr; 88(4):353-61. PubMed ID: 2435814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal interleukin-1 is increased in cutaneous T-cell lymphoma.
    Tron VA; Rosenthal D; Sauder DN
    J Invest Dermatol; 1988 Mar; 90(3):378-81. PubMed ID: 3279133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of murine and human epidermal cell-derived thymocyte-activating factor.
    Luger TA; Sztein MB; Schmidt JA; Murphy P; Grabner G; Oppenheim JJ
    Fed Proc; 1983 Jul; 42(10):2772-6. PubMed ID: 6602721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
    Luger TA; Uchida A; Köck A; Colot M; Micksche M
    J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultraviolet radiation inhibits alloantigen presentation by epidermal cells: partial reversal by the soluble epidermal cell product, epidermal cell-derived thymocyte-activating factor (ETAF).
    Sauder DN; Noonan FP; DeFabo EC; Katz SI
    J Invest Dermatol; 1983 Jun; 80(6):485-9. PubMed ID: 6222123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunomodulation using an epidermal cytokine (ETAF)].
    Luger TA; Niebauer G
    Z Hautkr; 1984 Jan; 59(1):18, 23-34. PubMed ID: 6367244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of an epidermal cell thymocyte-activating factor (ETAF) produced by human epidermal cells and a human squamous cell carcinoma cell line.
    Luger TA; Stadler BM; Luger BM; Sztein MB; Schmidt JA; Hawley-Nelson P; Grabner G; Oppenheim JJ
    J Invest Dermatol; 1983 Sep; 81(3):187-93. PubMed ID: 6604110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal anti-IL 1 is directed against a common site of human IL 1 alpha and IL 1 beta.
    Luger TA; Danner M; Köck A
    Immunobiology; 1986 Sep; 172(3-5):346-56. PubMed ID: 2433213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrocortisone reduces both constitutive and UV-elicited release of epidermal thymocyte activating factor (ETAF) by cultured keratinocytes.
    Kupper TS; McGuire J
    J Invest Dermatol; 1986 Nov; 87(5):570-3. PubMed ID: 3534102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1.
    Luger TA; Stadler BM; Luger BM; Mathieson BJ; Mage M; Schmidt JA; Oppenheim JJ
    J Immunol; 1982 May; 128(5):2147-52. PubMed ID: 6801132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic properties of epidermal cell thymocyte-activating factor (ETAF).
    Sauder DN
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):176s-179s. PubMed ID: 3874245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of in vitro and in vivo UV irradiation on the production of ETAF activity by human and murine keratinocytes.
    Ansel JC; Luger TA; Green I
    J Invest Dermatol; 1983 Dec; 81(6):519-23. PubMed ID: 6196420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis.
    Sauder DN; Mounessa NL; Katz SI; Dinarello CA; Gallin JI
    J Immunol; 1984 Feb; 132(2):828-32. PubMed ID: 6361134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new role for epidermal cell-derived thymocyte activating factor/IL-1 as an antagonist for distinct epidermal cell function.
    Swope VB; Abdel-Malek ZA; Sauder DN; Nordlund JJ
    J Immunol; 1989 Mar; 142(6):1943-9. PubMed ID: 2466081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of X-irradiation on epidermal immune function: decreased density and alloantigen-presenting capacity of Ia+ Langerhans cells and impaired production of epidermal cell-derived thymocyte activating factor (ETAF).
    Breathnach SM; Katz SI
    J Invest Dermatol; 1985 Dec; 85(6):553-8. PubMed ID: 3877770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of epidermal cell thymocyte-activating factor in the proliferation and differentiation of murine B cells.
    Pillai PS; Reynolds SD; Scott DW; Gauldie J; Sauder DN
    J Leukoc Biol; 1987 Sep; 42(3):222-9. PubMed ID: 3305747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells.
    Luger TA; Charon JA; Colot M; Micksche M; Oppenheim JJ
    J Immunol; 1983 Aug; 131(2):816-20. PubMed ID: 6602848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.